Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 2000

View Archived Issues

Prous Science presents: Case Histories of Drug Discovery

Company Profile: Siga

PAX9 gene mutation results in missing teeth

Delayed treatment with AM-36 reduces neuronal damage in stroke model

CV Therapeutics establishes Tangier drug discovery program

Addition of infliximab to methotrexate therapy reduces RA symptoms

Compounds and methods for treating or preventing HIV infection and AIDS

Japanese investigators prepare new agents for influenza

Novel Pfizer compounds useful for hyperproliferative disorders

Inhibitors of calmodulin-dependent PDE discovered at Daiichi

AstraZeneca presents new series of insulin sensitizers

Peptides binding to GRP receptors useful for diagnosis, treatment of certain tumors

Novel cis-cyclopropanes from BMS act as melatonin agonists

Cambridge NeuroScience and Algos enter pain management agreement

Maxamine granted orphan drug status for AML

Condensed heterocycles and ester prodrugs as potent antiplatelet, antithrombotic agents

Medarex enters cataract and cancer partnership with Scil Biomedicals

RWJ-67657 undergoes further study based on favorable preliminary biological profile

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...